The pilot "first order" of the joint supervision and innovation mechanism for the import of biomedical R&D articles in Hainan Free Trade Port landed

Haikou Customs released news on the 4th that on the same day, 2,750 key materials for biomedical research and development arrived at Haikou Meilan International Airport from Paris, France, and cleared and released after on-site inspection by Haikou Meilan Airport Customs under Haikou Customs, which is the "first order" of goods declared for import since the pilot of the joint supervision and innovation mechanism for the import of Hainan biomedical R&D items, marking the official landing of the pilot of the joint supervision and innovation mechanism for the import of biomedical R&D articles in Hainan Free Trade Port
.

 

It is reported that the batch of key materials for pharmaceutical research and development was imported by Qilu Pharmaceutical (Hainan) Co.
, Ltd.
and will be used for the research and development of a sub-project of a major national scientific research
project undertaken by the company.

 

The "Hainan Biomedical R&D Articles Import Joint Supervision and Innovation Mechanism Pilot Work Plan" (hereinafter referred to as the "Plan") is based on the background of the high-quality development of the biomedical industry in Hainan Free Trade Port, actively benchmarks the advanced international and domestic experience, and uses the Hainan Free Trade Port policy to take the lead and try first, and is formulated in the form of "small cuts"
.

 

The "Plan" stipulates that the list of pilot enterprises and the list of R&D items shall be established, a biosecurity risk assessment team shall be set up, and a joint risk assessment shall be carried out for the items to be imported for R&D in the list, and the enterprise shall apply to the Customs for the approval of the sanitary quarantine of entry-exit special items with the joint risk assessment report, and at the same time apply to the Hainan Provincial Food and Drug Administration for relevant certification materials, and go through customs clearance procedures with the Customs Entry and Exit Special Items Sanitary Quarantine Approval Form and the certification materials of the Hainan Provincial Food and Drug Administration, and the enterprise does not need to apply to the Hainan Provincial Food and Drug Administration for "Import" Drug Customs Clearance Form"
.
This move solves the problem that Hainan biomedical enterprises cannot obtain drug customs clearance forms for imported R&D items, and strengthens the safety supervision measures of R&D items, which is conducive to preventing biosecurity risks
.

 

In order to promote the smooth implementation of the project, Haikou Customs set up a special work class, cooperated with relevant local departments for many discussions, promoted the issuance of the Plan, and actively built a multi-department joint supervision mechanism
.
Jointly with the Haikou Municipal People's Government, the Haikou Municipal People's Government formulated the operating procedures for risk assessment of special items entering and exiting Haikou City, including Haikou Customs, Hainan Provincial Drug Administration, Hainan Provincial Health Commission, Hainan Provincial Drug Inspection Institute, and Hainan Provincial Diseases The Center for Prevention and Control, Hainan Medical College, Hainan University and other participating risk assessment expert teams guided Haikou National High-tech Industrial Development Zone to carry out the first joint risk assessment work of Qilu Pharmaceutical (Hainan) Co.
, Ltd
.
, guided enterprises to complete product filing and special item hygiene and quarantine approval, did a good job in customs clearance guarantee, and ensured the smooth landing of the pilot "first order".

 

In the next step, Haikou Customs will continue to explore and optimize the supervision process, expand the scope of risk assessment, help enterprises make good use of the policy dividends of the Hainan Free Trade Port, and promote the high-quality development of
Hainan's biomedical industry.